Navigation Links
ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
Date:9/9/2008

NEW AGREEMENT COVERS MARROWXPRESS(TM) IN KEY GLOBAL MARKETS

RANCHO CORDOVA, Calif., Sept. 9 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today it has signed a distribution agreement with Celling Technologies for ThermoGenesis' MarrowXpress (MXP(TM)) product line used for isolating stem cells from bone marrow. The distribution rights are for the field of use in orthopedic intraoperative or point-of-care applications.

Celling Technologies is an innovator in the research, development and marketing of medical devices for use in regenerative medicine. Celling Technologies provides the scientific resources and technical expertise to provide services in the evolving field of stem cell therapy.

Celling Technologies will begin using the MXP to perform bone marrow stem cell separation for its existing point-of-care orthopedic procedures and perform clinical research utilizing this unique technology. The MXP offers a computerized control in the separation of stem cells from bone marrow aspirate which is first to market technology allowing surgeons to automate the steps with consistent cell separation accuracy and cryopreservation capabilities. In the field of regenerative medicine, a high concentration of stem cells delivered back to the patient offers an environment conducive to tissue regeneration.

The five-year agreement provides Celling with an initial 2 year period of exclusive distribution rights in the U.S. and non-exclusive distribution rights throughout the rest of the world, excluding Central and South America, Russia and certain Eastern European countries. ThermoGenesis will establish distri
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent
2. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008
3. ThermoGenesis Names Tiffany Olson to Board of Directors
4. ThermoGenesis Announces FDA Authorization to Market MarrowXpress(TM) (MXP(TM))
5. ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)
6. ThermoGenesis Names Dr. Mahendra Rao to Board of Directors
7. ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health
8. ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
9. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
10. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
11. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., , SAN DIEGO, Nov. 25 /PRNewswire-FirstC...nnounced today that Barry D. Quart, Pharm.D., pres... the Piper Jaffray 21st Annual Health Care Confere...er Jaffray 21st Annual Health Care Conference,Date....m. Eastern Time,Location: The New York Palace Ho...
(Date:11/24/2009)..., , SANTA CRUZ, Calif., Nov. 24 /PRNew...oined Bio Career Center, the nation,s leading onli...fessionals. ,, Northwestern and Columbia Univer...other major life science training Institutions. ,...nly for post-graduates in the life sciences. While...
(Date:11/24/2009)..., , REYKJAVIK, Iceland, N...cs, Inc. (Nasdaq: DCGN ) today announced the appro...Bankruptcy Court for the District of Delaware,(the...untary petition for,relief under Chapter 11 of the... Court. , The orders issued by the Bankru...
(Date:11/24/2009)... The FBI recently approve...boratories participating in or generating DNA reco... Madison, WI USA (PRWEB) -- The FBI...HS System for use by laboratories participating i... Index System (NDIS). NDIS currently contains more...
Breaking Biology Technology:Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
... HIGHLIGHTS: 2008 Results (all percentage compar...Q2 2008 Sales Set New Quarterly Record: Q2 2008 s...0.7 million, an increase of 14.4%. All four bu...third successive quarter. Organic sales growt...ding the roughly one percentage point impact of th...
... show evidence of 90 billion tons of microbial org...he deep biosphere, in a research article published...orresponds to about one-tenth of the amount of car...uthors: Kai-Uwe Hinrichs and Julius Lipp of the Ce...University of Bremen, Germany; and Fumio Inagaki a...
...Newswire-FirstCall/ - Lorus Therapeutics Inc.,(Lor...he research and,development of pharmaceutical prod..., today reported financial results for the three a...ied otherwise, all amounts are in Canadian,dollars...ology studies for Lorus, lead anticancer small ...
Other Biology Technology:Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 2Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 3Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 4Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 5Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 6Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 7Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 8Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 9Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 10Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 11Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 12Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 13Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 14Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 15Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 16Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 17Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 18Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 19Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008 Diluted EPS. Q2 2008 Sales Rise 14.4%. 2008 Diluted EPS Forecast Raised $.05 to $2.62-$2.72. 2090 billion tons of microbial organisms live in the deep biosphere 290 billion tons of microbial organisms live in the deep biosphere 3Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 2Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 3Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 4Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 5Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 6Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 7Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 8
(Date:11/24/2009)...November 24, 2009) -- The Wildlife Conservation So...t the last remaining population of Siberian tigers...ng tide of poaching and habitat loss. , ...fficials of what needs to be done to protect remai... The report was released by the Siberia...
(Date:11/24/2009)...d is a matter of debate. A high-profile study a fe...ent of their carbon from trees and leaves, evidenc...d aquatic ecosystems. , But new research from th...y to be true. Algae provide a much richer diet for...h published this week in the Proceedings of the N...
(Date:11/24/2009)... in Spanish . , The presence of increased b...ry substances in the blood, hinders the loss and m...project of the University of Navarra conducted by ...l of Pharmacy. , The project, entitled "A nutrig...ontrol of body weight and inflammation," examines ...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3It can be predicted the reaction obese patients will have to a diet 2CareFusion Shipping Ventilators to CDC for National Emergency Preparedness 5575 1CareFusion Shipping Ventilators to CDC for National Emergency Preparedness 5575 2Four Pharmaceutical Companies Pay 24124 Million for Submission of False Claims to Medicaid 5570 1Four Pharmaceutical Companies Pay 24124 Million for Submission of False Claims to Medicaid 5570 2Four Pharmaceutical Companies Pay 24124 Million for Submission of False Claims to Medicaid 5570 3FDA Approves New Treatment for Advanced Form of Kidney Cancer 5565 1FDA Approves New Treatment for Advanced Form of Kidney Cancer 5565 2
...ernoon in Etosha National Park in northern Namibia...ing the horizon for elephants. "It,s so fantastic ...s, rhinos, zebras, ostriches--it,s the Garden of E...ersity School of Medicine, O,Connell-Rodwell has c...es to explore the mysterious and complex world of ...
...zebra mussels and carp, are invading the Great Lak...m. A study from McMaster University published in t...rch suggests that for the round goby, a recently i...ritory from native fish plays a key role in their ...ster,s Sigal Balshine, an assistant professor of p...
...hin a protective lipid membrane. The membrane is s...at transport nutrients, ions, and water into and o...ells recognize each other in the body, and make th...versity have now mapped out nearly all of the memb... coli. Their study is published this week in Scien...
Other Biology News:Scientists journey to southern Africa to unravel the secret world of elephant communication 2Scientists journey to southern Africa to unravel the secret world of elephant communication 3Scientists journey to southern Africa to unravel the secret world of elephant communication 4Scientists journey to southern Africa to unravel the secret world of elephant communication 5Scientists journey to southern Africa to unravel the secret world of elephant communication 6Scientists journey to southern Africa to unravel the secret world of elephant communication 7Scientists journey to southern Africa to unravel the secret world of elephant communication 8Scientists journey to southern Africa to unravel the secret world of elephant communication 9Scientists journey to southern Africa to unravel the secret world of elephant communication 10Scientists journey to southern Africa to unravel the secret world of elephant communication 11Scientists journey to southern Africa to unravel the secret world of elephant communication 12
Goat Anti-Mouse IGSF4 Polyclonal Antibody, Unconjugated from R&D Systems
Rat Anti-Mouse Activin RIB / ALK-4 Monoclonal Antibody, Unconjugated, Clone 207304 from R&D Systems
Normal Human Serum from 3H Biomedical AB
...s for SYBR Green, TaqMan, LNA spiked TaqMan, Methy...ghly specific primers are designed by avoiding cro...BLAST search results. Primer efficiency is enhance...fied by connecting to the Mfold server. Beacon Des...
Biology Products: